Skip to main content
OpenTrials
Completed

NCT Number: NCT00717795

Physical Activity Intervention for Lung Cancer Survivors

The purpose of this study is to learn how many lung cancer survivors will agree to a physical activity program. We also want to know if lung cancer survivors benefit from this program. This information will help us to develop our services for lung cancer survivors.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Memorial Sloan Kettering Cancer Center

New York, 10065, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis and treatment at MSKCC of primary NSCLC; and/or pulmonary carcinoid;
  • At least one year post thoracic surgical resection;
  • Have no evidence of NSCLC or any other cancer at the time of study enrollment and not receiving any cancer treatment;
  • Currently sedentary or insufficiently active, defined by the American College of Sports Medicine (ACSM) and the Centers for Disease Control and Prevention as less than a total of 150 minutes of at least moderate intensity PA per week;
  • Able to complete a six-minute walk test (6MWT);
  • Able to provide informed consent.

FOCUS GROUP ONLY:

  • Completed the Physical Activity program offered through this study (08067);

Exclusion criteria

  • Presence of one of the following medical factors at screening:
  • regular use of an ambulatory aid (cane or walker);
  • resting oxygen saturation less than 88%;
  • inability to walk due to severe arthritis or other musculoskeletal problems;
  • a diagnosis of unstable angina in the previous 6 weeks;
  • a heart attack, angioplasty or heart surgery in the previous 3 months;
  • current heart rate <50 or >120 at rest; current uncontrolled hypertension;
  • current significant valvular heart disease or decompensated congestive heart failure and
  • patient reported pain of any origin that would preclude participation in the proposed PA intervention
  • Evidence of significant medical cognitive or psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in the intervention
  • Self-reporting of greater than 60 minutes of vigorous activity per week or 150 minutes of moderate intensity PA per week.
  • Patient resides at more than two hours travel distance from the Center
  • Insufficient English fluency to complete evaluation tools.

Treatment and study plan

interview and physical activity

Behavioral

For Arm 1 participants in the Physical Activity intervention condition will be assessed at baseline, and postintervention Follow-up (at 12 weeks post baseline).

interview and wait list

Behavioral

Participants in the control condition (Arm 2)will be assessed at baseline and 12 weeks post baseline (Follow-up). At this time, the PA intervention will be offered at no cost to the participants in the control condition. If the waitlist participant chooses to complete the PA intervention after the 12 week waitlist period, program satisfaction will be assessed after study completion.

Primary outcomes

  1. To evaluate the feasibility (acceptability, adherence, treatment integrity, retention, participant satisfaction) of implementing a physical activity intervention trial among sedentary and insufficiently active lung cancer survivors.

    Time frame: conclusion of the study

Secondary outcomes

  1. Obtain preliminary data on effect of a physical activity intervention on functional ability, health-related QOL, dyspnea, fatigue, balance, strength & self-report physical activity among sedentary and insufficiently active lung cancer survivors

    Time frame: conclusion of the study

  2. To obtain preliminary data on factors associated with feasibility using variables from Social Cognitive Theory and assess their relationship with treatment adherence and dropout.

    Time frame: conclusion of the study

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Collaborators

  • Brown University
  • Fox Chase Cancer Center
  • University of Alberta

Registry information

Important dates

Study start
2008
Primary completion
2023
Study completion
2023
First posted
Jul 18, 2008
Registry last updated
Jun 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.